HK Stock MarketDetailed Quotes

LOCO HK (08162)

Watchlist
  • 0.600
  • -0.030-4.76%
Not Open May 20 16:01 CST
597.17MMarket Cap9.23P/E (TTM)

LOCO HK (08162) Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax
77.49%84.27M
162.77%24.73M
79.73%47.48M
300.30%9.41M
215.38%26.42M
113.64%2.35M
27.32%-22.9M
-30.75%-17.23M
31.45%-31.5M
29.74%-13.18M
Profit adjustment
Interest (income) - adjustment
-19,546.67%-8.84M
-4,600.00%-799K
-50.00%-45K
-70.00%-17K
-66.67%-30K
0.00%-10K
43.75%-18K
50.00%-10K
49.21%-32K
9.09%-20K
Interest expense - adjustment
809.86%7.29M
-68.28%131K
-23.71%801K
5.09%413K
379.45%1.05M
614.55%393K
67.18%219K
37.50%55K
84.51%131K
14.29%40K
Attributable subsidiary (profit) loss
----
----
----
----
-67.58%1.55M
-98.39%30K
1,166.40%4.79M
2,462.03%1.87M
520.00%378K
-31.67%-79K
Impairment and provisions:
-73.62%593K
431.38%1.27M
598.14%2.25M
17.16%239K
50.47%322K
537.50%204K
7.00%214K
-84.39%32K
-96.15%200K
-80.71%205K
-Impairment of trade receivables (reversal)
-73.62%593K
431.38%1.27M
598.14%2.25M
17.16%239K
50.47%322K
537.50%204K
7.00%214K
-84.39%32K
-44.90%200K
157.42%205K
Revaluation surplus:
89,473.33%26.81M
-42.42%-47K
-50.00%-30K
-650.00%-33K
-112.12%-20K
118.18%6K
685.71%165K
-925.00%-33K
-99.82%21K
-99.83%4K
-Derivative financial instruments fair value (increase)
--27.08M
----
----
----
----
----
----
----
----
----
-Other fair value changes
-783.33%-265K
-42.42%-47K
-50.00%-30K
-650.00%-33K
-112.12%-20K
118.18%6K
685.71%165K
-925.00%-33K
-99.82%21K
-99.83%4K
Asset sale loss (gain):
----
----
102.87%45K
----
---1.57M
----
----
----
----
----
-Loss (gain) from sale of subsidiary company
----
----
----
----
---1.57M
----
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
----
--45K
----
----
----
----
----
----
----
Depreciation and amortization:
-18.12%3.82M
-21.84%2.02M
32.17%4.66M
55.21%2.58M
-2.19%3.53M
-11.55%1.66M
-8.78%3.6M
-11.21%1.88M
0.48%3.95M
16.27%2.12M
Special items
-97.81%17K
----
--776K
----
----
----
-118.43%-148K
-106.17%-40K
-74.47%803K
-68.54%648K
Operating profit before the change of operating capital
103.73%113.96M
116.81%27.3M
78.99%55.93M
171.65%12.59M
322.07%31.25M
134.38%4.64M
45.97%-14.07M
-31.34%-13.48M
-18.22%-26.05M
10.72%-10.27M
Change of operating capital
Accounts receivable (increase)decrease
203.69%602.69M
-1,782.86%-1.87B
-74.33%-581.23M
-4,629.50%-99.23M
-1,729.00%-333.41M
24.26%-2.1M
-282.16%-18.23M
78.80%-2.77M
-123.81%-4.77M
-155.68%-13.07M
Accounts payable increase (decrease)
-163.85%-324.93M
2,379.33%2.13B
62.82%508.92M
27,258.36%86.09M
182,684.80%312.56M
-128.28%-317K
29.55%171K
-73.12%1.12M
170.59%132K
--4.17M
Special items for working capital changes
-200.00%-28.25M
---28.25M
770.20%28.25M
----
-196.79%-4.22M
---4.22M
--4.36M
----
----
----
Cash  from business operations
2,961.32%363.47M
49,046.49%265.29M
91.87%11.87M
72.83%-542K
122.28%6.19M
86.82%-2M
9.48%-27.78M
21.03%-15.13M
-1,301.78%-30.69M
-278.32%-19.16M
Other taxs
-64.13%-10.57M
-14.71%-4.2M
-30.59%-6.44M
-104.07%-3.66M
---4.93M
---1.79M
----
----
99.58%-23K
99.53%-23K
Net cash from operations
6,397.85%352.9M
6,318.03%261.1M
332.75%5.43M
-10.88%-4.2M
104.52%1.26M
74.97%-3.79M
9.55%-27.78M
21.13%-15.13M
-299.12%-30.71M
-427.20%-19.18M
Cash flow from investment activities
Interest received - investment
2,342.42%806K
7,109.09%793K
73.68%33K
120.00%11K
216.67%19K
66.67%5K
-64.71%6K
-75.00%3K
-63.83%17K
-14.29%12K
Decrease in deposits (increase)
---360.39M
----
----
----
----
----
----
----
----
----
Sale of fixed assets
----
----
--36K
----
----
----
----
----
----
----
Purchase of fixed assets
---38K
---37K
----
----
---64K
---22K
----
----
-50.32%-1.19M
-25.54%-526K
Sale of subsidiaries
----
----
----
----
--10K
----
----
----
----
----
Recovery of cash from investments
----
----
----
----
309.52%4.3M
----
--1.05M
--1.05M
----
----
Cash on investment
----
----
----
----
----
----
----
----
---1.08M
----
Net cash from investment operations
-521,291.30%-359.62M
6,772.73%756K
-98.38%69K
164.71%11K
303.88%4.27M
-101.61%-17K
146.89%1.06M
304.86%1.05M
-203.50%-2.25M
-26.91%-514K
Net cash before financing
-222.25%-6.72M
6,352.41%261.85M
-0.36%5.5M
-10.09%-4.19M
120.66%5.52M
72.98%-3.8M
18.94%-26.72M
28.53%-14.08M
-290.71%-32.96M
-460.90%-19.7M
Cash flow from financing activities
New borrowing
----
-146.10%-26.05M
40.63%93M
653.52%56.51M
387.71%66.13M
--7.5M
352.00%13.56M
----
--3M
----
Refund
71.05%-26.05M
----
-63.41%-89.99M
----
-3,546.95%-55.07M
----
49.67%-1.51M
----
---3M
----
Issuing shares
--79.62M
--79.62M
----
----
----
----
----
----
62.44%27.65M
----
Interest paid - financing
77.15%-183K
27.34%-93K
23.71%-801K
9.22%-128K
-379.45%-1.05M
-156.36%-141K
-67.18%-219K
-96.43%-55K
-84.51%-131K
20.00%-28K
Absorb investment income
----
----
----
----
--38K
----
----
----
-5.28%466K
----
Issuance expenses and redemption of securities expenses
---800K
---800K
----
----
----
----
----
----
-5.93%-411K
----
Net cash from financing operations
7,851.85%50.23M
-6.36%51.32M
-110.18%-648K
762.21%54.8M
-34.93%6.37M
619.71%6.36M
-60.64%9.78M
21.70%-1.22M
217.47%24.86M
-102.07%-1.56M
Effect of rate
-262.20%-133K
-1,225.00%-495K
-68.82%82K
-71.61%44K
11.44%263K
-29.55%155K
1,023.81%236K
10,900.00%220K
-97.52%21K
100.34%2K
Net Cash
796.70%43.51M
518.73%313.17M
-59.18%4.85M
1,883.31%50.61M
170.18%11.89M
116.68%2.55M
-108.96%-16.94M
28.03%-15.3M
-1,235.26%-8.11M
-553.79%-21.26M
Begining period cash
30.22%21.26M
30.22%21.26M
290.65%16.33M
290.65%16.33M
-79.98%4.18M
-79.98%4.18M
-27.91%20.88M
-27.91%20.88M
0.84%28.96M
0.84%28.96M
Cash at the end
203.99%64.64M
398.51%333.93M
30.22%21.26M
872.66%66.99M
290.65%16.33M
18.76%6.89M
-79.98%4.18M
-24.75%5.8M
-27.91%20.88M
-76.53%7.71M
Cash balance analysis
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Cash flow from operating activities
Earning before tax 77.49%84.27M162.77%24.73M79.73%47.48M300.30%9.41M215.38%26.42M113.64%2.35M27.32%-22.9M-30.75%-17.23M31.45%-31.5M29.74%-13.18M
Profit adjustment
Interest (income) - adjustment -19,546.67%-8.84M-4,600.00%-799K-50.00%-45K-70.00%-17K-66.67%-30K0.00%-10K43.75%-18K50.00%-10K49.21%-32K9.09%-20K
Interest expense - adjustment 809.86%7.29M-68.28%131K-23.71%801K5.09%413K379.45%1.05M614.55%393K67.18%219K37.50%55K84.51%131K14.29%40K
Attributable subsidiary (profit) loss -----------------67.58%1.55M-98.39%30K1,166.40%4.79M2,462.03%1.87M520.00%378K-31.67%-79K
Impairment and provisions: -73.62%593K431.38%1.27M598.14%2.25M17.16%239K50.47%322K537.50%204K7.00%214K-84.39%32K-96.15%200K-80.71%205K
-Impairment of trade receivables (reversal) -73.62%593K431.38%1.27M598.14%2.25M17.16%239K50.47%322K537.50%204K7.00%214K-84.39%32K-44.90%200K157.42%205K
Revaluation surplus: 89,473.33%26.81M-42.42%-47K-50.00%-30K-650.00%-33K-112.12%-20K118.18%6K685.71%165K-925.00%-33K-99.82%21K-99.83%4K
-Derivative financial instruments fair value (increase) --27.08M------------------------------------
-Other fair value changes -783.33%-265K-42.42%-47K-50.00%-30K-650.00%-33K-112.12%-20K118.18%6K685.71%165K-925.00%-33K-99.82%21K-99.83%4K
Asset sale loss (gain): --------102.87%45K-------1.57M--------------------
-Loss (gain) from sale of subsidiary company -------------------1.57M--------------------
-Loss (gain) on sale of property, machinery and equipment ----------45K----------------------------
Depreciation and amortization: -18.12%3.82M-21.84%2.02M32.17%4.66M55.21%2.58M-2.19%3.53M-11.55%1.66M-8.78%3.6M-11.21%1.88M0.48%3.95M16.27%2.12M
Special items -97.81%17K------776K-------------118.43%-148K-106.17%-40K-74.47%803K-68.54%648K
Operating profit before the change of operating capital 103.73%113.96M116.81%27.3M78.99%55.93M171.65%12.59M322.07%31.25M134.38%4.64M45.97%-14.07M-31.34%-13.48M-18.22%-26.05M10.72%-10.27M
Change of operating capital
Accounts receivable (increase)decrease 203.69%602.69M-1,782.86%-1.87B-74.33%-581.23M-4,629.50%-99.23M-1,729.00%-333.41M24.26%-2.1M-282.16%-18.23M78.80%-2.77M-123.81%-4.77M-155.68%-13.07M
Accounts payable increase (decrease) -163.85%-324.93M2,379.33%2.13B62.82%508.92M27,258.36%86.09M182,684.80%312.56M-128.28%-317K29.55%171K-73.12%1.12M170.59%132K--4.17M
Special items for working capital changes -200.00%-28.25M---28.25M770.20%28.25M-----196.79%-4.22M---4.22M--4.36M------------
Cash  from business operations 2,961.32%363.47M49,046.49%265.29M91.87%11.87M72.83%-542K122.28%6.19M86.82%-2M9.48%-27.78M21.03%-15.13M-1,301.78%-30.69M-278.32%-19.16M
Other taxs -64.13%-10.57M-14.71%-4.2M-30.59%-6.44M-104.07%-3.66M---4.93M---1.79M--------99.58%-23K99.53%-23K
Net cash from operations 6,397.85%352.9M6,318.03%261.1M332.75%5.43M-10.88%-4.2M104.52%1.26M74.97%-3.79M9.55%-27.78M21.13%-15.13M-299.12%-30.71M-427.20%-19.18M
Cash flow from investment activities
Interest received - investment 2,342.42%806K7,109.09%793K73.68%33K120.00%11K216.67%19K66.67%5K-64.71%6K-75.00%3K-63.83%17K-14.29%12K
Decrease in deposits (increase) ---360.39M------------------------------------
Sale of fixed assets ----------36K----------------------------
Purchase of fixed assets ---38K---37K-----------64K---22K---------50.32%-1.19M-25.54%-526K
Sale of subsidiaries ------------------10K--------------------
Recovery of cash from investments ----------------309.52%4.3M------1.05M--1.05M--------
Cash on investment -----------------------------------1.08M----
Net cash from investment operations -521,291.30%-359.62M6,772.73%756K-98.38%69K164.71%11K303.88%4.27M-101.61%-17K146.89%1.06M304.86%1.05M-203.50%-2.25M-26.91%-514K
Net cash before financing -222.25%-6.72M6,352.41%261.85M-0.36%5.5M-10.09%-4.19M120.66%5.52M72.98%-3.8M18.94%-26.72M28.53%-14.08M-290.71%-32.96M-460.90%-19.7M
Cash flow from financing activities
New borrowing -----146.10%-26.05M40.63%93M653.52%56.51M387.71%66.13M--7.5M352.00%13.56M------3M----
Refund 71.05%-26.05M-----63.41%-89.99M-----3,546.95%-55.07M----49.67%-1.51M-------3M----
Issuing shares --79.62M--79.62M------------------------62.44%27.65M----
Interest paid - financing 77.15%-183K27.34%-93K23.71%-801K9.22%-128K-379.45%-1.05M-156.36%-141K-67.18%-219K-96.43%-55K-84.51%-131K20.00%-28K
Absorb investment income ------------------38K-------------5.28%466K----
Issuance expenses and redemption of securities expenses ---800K---800K-------------------------5.93%-411K----
Net cash from financing operations 7,851.85%50.23M-6.36%51.32M-110.18%-648K762.21%54.8M-34.93%6.37M619.71%6.36M-60.64%9.78M21.70%-1.22M217.47%24.86M-102.07%-1.56M
Effect of rate -262.20%-133K-1,225.00%-495K-68.82%82K-71.61%44K11.44%263K-29.55%155K1,023.81%236K10,900.00%220K-97.52%21K100.34%2K
Net Cash 796.70%43.51M518.73%313.17M-59.18%4.85M1,883.31%50.61M170.18%11.89M116.68%2.55M-108.96%-16.94M28.03%-15.3M-1,235.26%-8.11M-553.79%-21.26M
Begining period cash 30.22%21.26M30.22%21.26M290.65%16.33M290.65%16.33M-79.98%4.18M-79.98%4.18M-27.91%20.88M-27.91%20.88M0.84%28.96M0.84%28.96M
Cash at the end 203.99%64.64M398.51%333.93M30.22%21.26M872.66%66.99M290.65%16.33M18.76%6.89M-79.98%4.18M-24.75%5.8M-27.91%20.88M-76.53%7.71M
Cash balance analysis
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More